Millions of Americans who got the Moderna or Johnson & Johnson COVID-19 vaccines will soon learn when they'll be eligible for booster shots.
should be dispensed and, if so, who should get them and when. The final go-ahead is not expected for at least another week.
After the FDA advisors give their recommendation, the agency itself will make a decision on whether to authorize boosters. Then next week, a panel convened by the Centers for Disease Control and Prevention will offer more specifics on who should get them. Its decision is subject to approval by the CDC director.The process is meant to bolster public confidence in the vaccines.
In a vaccine dispute last month, the CDC’s advisory panel backed Pfizer boosters at the six-month point only for older Americans, nursing home residents and people with underlying health problems. But CDC Director Dr. Rochelle Walenskyand decided boosters should also be offered to those with high-risk jobs, such as teachers and healthcare workers, adding tens of millions more Americans to the list.
Some health experts fear the back-and-forth deliberations are muddling the public effort to persuade the unvaccinated to get their first shots. They worry that the talk of boosters will lead people to wrongly doubt the effectiveness of the vaccines in the first place.We look at the science behind the need for COVID-19 booster shots.
When the FDA’s panel meets to review the Moderna and J&J vaccines, experts will discuss whether a third Moderna shot should contain just half the original dose and what the best timing would be for
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Next on FDA's agenda: Booster shots of Moderna, J&J vaccinesMany Americans who got the Pfizer shots are rolling up their sleeves for a booster shot, but millions of others who got the Moderna or Johnson & Johnson vaccine wait to learn when it's their turn. Federal regulators will answer that question this week.
Baca lebih lajut »
U.S. moves closer to clearing Moderna and J&J Covid booster shots this weekThe FDA's vaccine advisory committee meeting come less than a month after U.S. regulators authorized third Covid shots of Pfizer's vaccine.
Baca lebih lajut »
Moderna asks for booster clearance ahead of FDA panel meetingsAn FDA advisory committee will meet Thursday and Friday to discuss booster doses for the Moderna and Johnson & Johnson Covid vaccines.
Baca lebih lajut »
U.S. FDA staff says Moderna did not meet all criteria for COVID-19 boostersScientists at the U.S. Food and Drug Administration said on Tuesday that Moderna Inc had not met all of the agency's criteria to support use of booster doses of its COVID-19 vaccine, possibly because the efficacy of the shot's first two doses has remained strong.
Baca lebih lajut »
Moderna to increase COVID vaccine production rather than share formula with others'Within the next six to nine months, the most reliable way to make high-quality vaccines and in an efficient way is going to be if we make them,' Moderna said.
Baca lebih lajut »